Clinical blindness in conjunction with childhood bacterial meningitis.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
19 09 2023
Historique:
received: 30 01 2023
accepted: 30 08 2023
medline: 21 9 2023
pubmed: 20 9 2023
entrez: 19 9 2023
Statut: epublish

Résumé

Although rarely reported, bilateral loss of vision is a severe complication of childhood bacterial meningitis. We assessed its frequency in five prospective treatment trials performed in Europe, Latin America, and Angola in 1984-2017. Course of illness, follow-up findings, and child's sight were recorded. Sight was examined at discharge, and conditions permitting, also at 1-3 months post-hospitalization and in Angola on hospital day 7. Experienced pediatricians diagnosed clinical blindness if the child did not make eye contact, did not blink or move the eyes, or remained unresponsive to bright light or movement of large objects before their eyes. Of 1515 patients, 351, 654, and 510 were from Finland, Latin America, and Angola, respectively. At discharge, blindness was observed in 0 (0%), 8 (1.2%), and 51 (10%) children, respectively. In Angola, 64 children appeared to be blind on day 7; 16 of these children died. Blindness found at discharge in Angola was not invariably irreversible; approximately 40% had restored the sight at follow-up visit. Clinical blindness rarely occurred in isolation and was usually associated with young age and poor general condition at hospital arrival. Various other serious sequelae were common among the survivors with clinical blindness.

Identifiants

pubmed: 37726355
doi: 10.1038/s41598-023-41685-2
pii: 10.1038/s41598-023-41685-2
pmc: PMC10509259
doi:

Banques de données

ISRCTN
['ISRCTN62824827']
ClinicalTrials.gov
['NCT 01540838']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

15530

Informations de copyright

© 2023. Springer Nature Limited.

Références

Lancet Neurol. 2022 May;21(5):450-464
pubmed: 35429482
Pediatr Infect Dis J. 1995 Apr;14(4):270-8
pubmed: 7603807
N Engl J Med. 1990 Dec 13;323(24):1651-7
pubmed: 2233962
J Pediatr. 1978 Aug;93(2):253-4
pubmed: 671161
Pediatr Infect Dis J. 2006 Jun;25(6):566-7
pubmed: 16732162
J Neurol Sci. 2017 Apr 15;375:27-34
pubmed: 28320145
Ann Paediatr Fenn. 1961;7:283-9
pubmed: 13903340
Br J Clin Pharmacol. 1991 Sep;32(3):311-5
pubmed: 1777366
S Afr Med J. 1997 Aug;87(8 Suppl):1052-4
pubmed: 9323430
Acta Ophthalmol Suppl. 1960;Suppl 61:1-54
pubmed: 13770434
Sci Rep. 2021 Nov 3;11(1):21593
pubmed: 34732790
Lancet Infect Dis. 2011 Aug;11(8):613-21
pubmed: 21550313
Clin Infect Dis. 2008 Apr 15;46(8):1248-52
pubmed: 18444863
Dev Med Child Neurol. 2008 Apr;50(4):267-74
pubmed: 18312424
Pediatr Infect Dis J. 2014 Mar;33(3):253-7
pubmed: 24569385
BMC Med. 2009 Sep 14;7:47
pubmed: 19751516
Neurol Sci. 2016 Jan;37(1):139-141
pubmed: 26343036
Lancet. 1989 Jun 10;1(8650):1281-7
pubmed: 2566824
Dev Med Child Neurol. 1984 Apr;26(2):227-30
pubmed: 6724161
Clin Infect Dis. 2007 Nov 15;45(10):1277-86
pubmed: 17968821
Clin Infect Dis. 2021 May 18;72(10):1738-1744
pubmed: 32246138
Clin Infect Dis. 2009 Mar 1;48 Suppl 2:S90-6
pubmed: 19191624

Auteurs

Tuula Pelkonen (T)

Pediatrics, University of Helsinki and Helsinki University Hospital, Stenbäckinkatu 9, 00029, Helsinki, Finland. tuulapelkonen@hotmail.com.
New Children's Hospital, Pediatric Research Center, P.O. Box 347, 00029 HUS, Helsinki, Finland. tuulapelkonen@hotmail.com.
Hospital Pediátrico David Bernardino, Luanda, Angola. tuulapelkonen@hotmail.com.

Markku Kallio (M)

Pediatrics, University of Helsinki and Helsinki University Hospital, Stenbäckinkatu 9, 00029, Helsinki, Finland.

Terho Latvala (T)

Ophthalmology, Helsinki University Hospital, and University of Helsinki, Helsinki, Finland.

Irmeli Roine (I)

Faculty of Medicine, University Diego Portales, Santiago, Chile.

Heikki Peltola (H)

Pediatrics, University of Helsinki and Helsinki University Hospital, Stenbäckinkatu 9, 00029, Helsinki, Finland. heiheikkipeltola@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH